Development of a New Risk Stratification Scheme to Predict Warfarin-Associated Hemorrhage: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study

被引：0
|
作者：
Fang, Margaret C.
Go, Alan S.
Chang, Yuchiao
Borowsky, Leila H.
Pomernacki, Niela K.
Udaltsova, Natalia
Singer, Daniel E.
机构：
[1] UCSF, San Francisco, CA USA
[2] Kaiser Permanente No Calif, Oakland, CA USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Anticoagulation; Atrial fibrillation; Risk factors;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16443
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation
    DeSilvey, DL
    AMERICAN JOURNAL OF GERIATRIC CARDIOLOGY, 2005, 14 (02): : 98 - 99
  • [42] Warfarin therapy in patients with atrial fibrillation: risk of intracranial hemorrhage
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 (1): : 6 - 6
  • [43] Letter by Barrios et al Regarding Article, "Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study"
    Barrios, Vivencio
    Escobar, Carlos
    Echarri, Rocio
    CIRCULATION, 2009, 120 (18) : E153 - E153
  • [44] Risk of Hemorrhage and Treatment Costs Associated With Warfarin Drug Interactions in Patients With Atrial Fibrillation
    Suh, Dong-Churl
    Nelson, Winnie W.
    Choi, Jiyoon C.
    Choi, Insun
    CLINICAL THERAPEUTICS, 2012, 34 (07) : 1569 - 1582
  • [45] Assessing the net clinical benefit of warfarin by ischemic stroke risk in atrial fibrillation: The ATRIA study
    Singer, Daniel E.
    Chang, Yuchiao
    Fang, Margaret C.
    Borowsky, Leila H.
    Pomernacki, Niela K.
    Udaltsova, Natalia
    Go, Alan S.
    STROKE, 2008, 39 (02) : 556 - 557
  • [46] WARFARIN ANTICOAGULATION THERAPY AND MORTALITY FOLLOWING GASTROINTESTINAL HEMORRHAGE IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL CARE: THE ATRIA AND ATRIA-CVRN COHORTS
    Ashburner, Jeffrey M.
    Go, Alan S.
    Reynolds, Kristi
    Chang, Yuchiao
    Fang, Margaret
    Fredman, Lisa
    Singer, Daniel E.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 : S240 - S240
  • [47] Anticoagulant intensity and risk of intracranial hemorrhage: Impact of case-control vs. case-crossover methods, the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
    Fang, MC
    Chang, Y
    Go, AS
    Hylek, EM
    Singer, DE
    CIRCULATION, 2004, 109 (07) : E103 - E103
  • [48] USE OF WARFARIN THERAPY AND RISK STRATIFICATION TOOLS FOR ATRIAL FIBRILLATION PATIENTS
    Winfield, Julia
    Barnes, Geoffrey D.
    Kaatz, Scott
    Gu, Xiaokui
    Kline-Rogers, Eva
    Kozlowski, Jay
    Hickman, Leaden
    Leyden, Thomas
    Besley, Dennis
    Haymart, Brian
    Leidal, Adam
    Theurer, Allison
    Froehlich, James B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1245 - E1245
  • [49] Use of warfarin and performance of stroke risk stratification models in atrial fibrillation
    Tamariz, Leonardo
    Parris, Donald
    Chirinos, Julio
    Lopez-Sanabria, Bernardo
    Chen, Gordon
    Palacio, Ana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 5A - 5A
  • [50] Use of warfarin and performance of stroke risk stratification models in atrial fibrillation
    Palacio, A.
    Parris, D.
    Chirinos, J.
    Lopez-Sanabria, B.
    Chen, G.
    Florez, H.
    Tamariz, L.
    EUROPEAN HEART JOURNAL, 2006, 27 : 836 - 836
12345